Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: The impact of quantitative magnetization transfer MR imaging

Multi-parametric and quantitative magnetic resonance imaging (MRI) techniques have come into the focus of interest, both as a research and diagnostic modality for the evaluation of patients suffering from mild cognitive decline and overt dementia. In this study we address the question, if disease related quantitative magnetization transfer effects (qMT) within the intra- and extracellular matrices of the hippocampus may aid in the differentiation between clinically diagnosed patients with Alzheimer disease (AD), patients with mild cognitive impairment (MCI) and healthy controls. We evaluated 22 patients with AD (n=12) and MCI (n=10) and 22 healthy elderly (n=12) and younger (n=10) controls with multi-parametric MRI. Neuropsychological testing was performed in patients and elderly controls (n=34). In order to quantify the qMT effects, the absorption spectrum was sampled at relevant off-resonance frequencies. The qMT-parameters were calculated according to a two-pool spin-bath model including the T1- and T2 relaxation parameters of the free pool, determined in separate experiments. Histograms (fixed bin-size) of the normalized qMT-parameter values (z-scores) within the anterior and posterior hippocampus (hippocampal head and body) were subjected to a fuzzy-c-means classification algorithm with downstreamed PCA projection. The within-cluster sums of point-to-centroid distances were used to examine the effects of qMT- and diffusion anisotropy parameters on the discrimination of healthy volunteers, patients with Alzheimer and MCIs. The qMT-parameters T2(r) (T2 of the restricted pool) and F (fractional pool size) differentiated between the three groups (control, MCI and AD) in the anterior hippocampus. In our cohort, the MT ratio, as proposed in previous reports, did not differentiate between MCI and AD or healthy controls and MCI, but between healthy controls and AD.

[1]  James C. Gee,et al.  Spatial transformations of diffusion tensor magnetic resonance images , 2001, IEEE Transactions on Medical Imaging.

[2]  D. Yeung,et al.  Super-resolution through neighbor embedding , 2004, CVPR 2004.

[3]  K. Titani,et al.  In vivo phosphorylation sites in fetal and adult rat tau. , 1993, The Journal of biological chemistry.

[4]  Eric O. Postma,et al.  Dimensionality Reduction: A Comparative Review , 2008 .

[5]  Geoffrey E. Hinton,et al.  The EM algorithm for mixtures of factor analyzers , 1996 .

[6]  W. Strik,et al.  The amygdala in schizophrenia: a trimodal magnetic resonance imaging study , 2005, Neuroscience Letters.

[7]  F. Schmitt,et al.  Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.

[8]  Mikhail Belkin,et al.  Semi-Supervised Learning on Riemannian Manifolds , 2004, Machine Learning.

[9]  G. B. Pike,et al.  Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI , 2001, Magnetic resonance in medicine.

[10]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[11]  Hirofumi Sakurai,et al.  Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer’s disease , 1999, Journal of the Neurological Sciences.

[12]  K. Davis,et al.  Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. , 1998, Archives of neurology.

[13]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[14]  J R MacFall,et al.  Methodology for the measurement and analysis of relaxation times in proton imaging. , 1987, Magnetic resonance imaging.

[15]  A. Haase,et al.  Snapshot flash mri. applications to t1, t2, and chemical‐shift imaging , 1990, Magnetic resonance in medicine.

[16]  V. Gallai†,et al.  Magnetization transfer changes of grey and white matter in Parkinson's disease , 2003, Neuroradiology.

[17]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[18]  W. M. van der Flier,et al.  Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease , 2002, Annals of neurology.

[19]  F. Barkhof,et al.  Magnetization transfer imaging of the spinal cord and the optic nerve in patients with multiple sclerosis. , 1999, Neurology.

[20]  Nick C. Fox,et al.  Quantitative Magnetization Transfer Imaging in Alzheimer , 2007 .

[21]  A. Izenman Recent Developments in Nonparametric Density Estimation , 1991 .

[22]  I. Furó,et al.  NMR magnetization transfer as a tool for characterization of nanoporous materials. , 2003, Magnetic resonance imaging.

[23]  Scott T. Grafton,et al.  Automated image registration: I. General methods and intrasubject, intramodality validation. , 1998, Journal of computer assisted tomography.

[24]  Andrea Federspiel,et al.  Examining the gateway to the limbic system with diffusion tensor imaging: The perforant pathway in dementia , 2006, NeuroImage.

[25]  Y. Joanette,et al.  Structural correlates of cognitive deficits in a selected group of patients with Alzheimer's disease. , 1998, Neuropsychiatry, neuropsychology, and behavioral neurology.

[26]  M Takasaki,et al.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia. , 2000, AJNR. American journal of neuroradiology.

[27]  T. Benzinger,et al.  Two-Dimensional Structure of β-Amyloid(10−35) Fibrils† , 2000 .

[28]  Why does MTR change with neuronal depolarization? , 2002, Magnetic resonance in medicine.

[29]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[30]  J Bohl,et al.  Staging of Alzheimer-Related Cortical Destruction , 1997, International Psychogeriatrics.

[31]  W. W. Hansen,et al.  The Nuclear Induction Experiment , 1946 .

[32]  K. Ishii,et al.  The LPS receptor (CD14) links innate immunity with Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  A. R. Damasio,et al.  Memory‐related neural systems in Alzheimer's disease , 1990, Neurology.

[34]  Rui Xu,et al.  Wavelet-based Multiresolution Medical Image Registration Strategy Combining Mutual Information with Spatial Information , 2006 .

[35]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[36]  M F Weiner,et al.  A total score for the CERAD neuropsychological battery , 2005, Neurology.

[37]  Howard Chertkow,et al.  Regional magnetization transfer ratio changes in mild cognitive impairment , 2002, Magnetic resonance in medicine.

[38]  V. Dousset,et al.  Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. , 1999, Neurology.

[39]  I Levesque,et al.  Regional variations in normal brain shown by quantitative magnetization transfer imaging , 2004, Magnetic resonance in medicine.

[40]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[41]  H. Neumann,et al.  LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. , 2005, Brain : a journal of neurology.

[42]  Ariel Fernández,et al.  Dielectric modulation of biological water. , 2004, Physical review letters.

[43]  R S Balaban,et al.  Magnetization transfer contrast in magnetic resonance imaging. , 1992, Magnetic resonance quarterly.

[44]  Alan C. Evans,et al.  Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. , 2000, Cerebral cortex.

[45]  S. Mirra,et al.  Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. , 1993, Archives of pathology & laboratory medicine.

[46]  J. Troncoso,et al.  Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.

[47]  J. Morrison,et al.  Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease , 2002, Neuroscience.

[48]  Jacek M. Leski,et al.  Towards a robust fuzzy clustering , 2003, Fuzzy Sets Syst..

[49]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[50]  Thomas Dierks,et al.  Volumetry and diffusion tensor imaging of hippocampal subregions in schizophrenia , 2004, Neuroreport.

[51]  A. Izenman Review Papers: Recent Developments in Nonparametric Density Estimation , 1991 .

[52]  M. F. Falangola,et al.  Quantitative MRI reveals aging‐associated T2 changes in mouse models of Alzheimer's disease , 2007, NMR in biomedicine.

[53]  K. Davis,et al.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.

[54]  Yonathan Bard,et al.  Nonlinear parameter estimation , 1974 .

[55]  James C. Bezdek,et al.  A Convergence Theorem for the Fuzzy ISODATA Clustering Algorithms , 1980, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[56]  G. Scotti,et al.  Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI , 2001, Neurology.

[57]  M Takasaki,et al.  [Atrophy and magnetization transfer ratio of the corpus callosum in patients with Alzheimer's disease]. , 1998, Rinsho shinkeigaku = Clinical neurology.

[58]  B T Hyman,et al.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.

[59]  Pervin Iseri,et al.  Magnetization transfer ratio in early period of Parkinson disease. , 2007, Academic radiology.

[60]  T. Brubaker,et al.  Nonlinear Parameter Estimation , 1979 .

[61]  H. Hanyu,et al.  Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease , 2001, Journal of the Neurological Sciences.

[62]  Claus Kiefer,et al.  Differentiating hippocampal subregions by means of quantitative magnetization transfer and relaxometry: preliminary results , 2004, NeuroImage.

[63]  L. Ingber Very fast simulated re-annealing , 1989 .

[64]  S. Black,et al.  Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer’s disease , 1998, Neuropsychologia.

[65]  Donald Gustafson,et al.  Fuzzy clustering with a fuzzy covariance matrix , 1978, 1978 IEEE Conference on Decision and Control including the 17th Symposium on Adaptive Processes.

[66]  P. Scheltens,et al.  Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.

[67]  Toshio Mizutani,et al.  Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia , 1997, Neuroscience Letters.

[68]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[69]  G. Pike,et al.  Correction for B1 and B0 variations in quantitative T2 measurements using MRI , 2000, Magnetic resonance in medicine.

[70]  James M. Keller,et al.  Fuzzy Models and Algorithms for Pattern Recognition and Image Processing , 1999 .

[71]  N. Draper,et al.  Applied Regression Analysis. , 1967 .

[72]  J. Price,et al.  Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.

[73]  T. W. Anderson ASYMPTOTIC THEORY FOR PRINCIPAL COMPONENT ANALYSIS , 1963 .

[74]  Larry L. Butcher,et al.  Prolongation of magnetic resonance T 2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease , 1992, Neuroscience Letters.

[75]  G. Pike,et al.  Quantitative interpretation of magnetization transfer in spoiled gradient echo MRI sequences. , 2000, Journal of magnetic resonance.

[76]  L. Parnetti,et al.  CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies , 2001, Neurological Sciences.